SCHEMBL30529877

SCHEMBL30529877

Cc1ccc(Br)cc1Cc1ccc(-c2ccccc2)s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 2/20 0.45
▸ CYP2C9 P11712 2/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ CYP2E1 P05181 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2B6 P20813 1/20 0.45
▸ SLC5A2 P31639 7/20 0.43
▸ ABCB11 O95342 1/20 0.43
▸ ADORA3 P0DMS8 1/20 0.43
▸ SLC5A1 P13866 1/20 0.43
▸ SLC6A4 P31645 1/20 0.43
▸ SLC6A3 Q01959 1/20 0.43
▸ CYP11B1 P15538 1/20 0.36
▸ CYP11B2 P19099 1/20 0.36
▸ HDAC3 O15379 2/20 0.36
▸ HDAC1 Q13547 2/20 0.36
▸ HDAC2 Q92769 2/20 0.36
▸ HDAC8 Q9BY41 2/20 0.36
▸ NR3C2 P08235 1/20 0.35
▸ HSD17B1 P14061 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL155560 1.00 CYP2A6 (0.45) CYP2A6CYP2C9CYP2C19CYP2E1CYP3A4
SCHEMBL5974952 0.91 SLC5A2 (0.39) CYP2A6CYP2C9CYP2C19CYP2E1CYP3A4
SCHEMBL156898 0.91 SLC5A2 (0.41) CYP2A6CYP2C9CYP2C19CYP2E1CYP3A4
SCHEMBL18505674 0.89 SLC5A2 (0.43) CYP2A6CYP2C9CYP2C19CYP2E1CYP3A4
SCHEMBL155572 0.88 SLC5A2 (0.49) CYP2A6CYP2C9CYP2C19CYP2E1CYP3A4
SCHEMBL155881 0.88 SLC5A2 (0.40) CYP2A6CYP2C9CYP2C19CYP2E1CYP3A4
SCHEMBL152991 0.87 SLC5A2 (0.39) CYP2A6CYP2C9CYP2C19CYP2E1CYP3A4
SCHEMBL29366717 0.86 SLC5A2 (0.54) SLC5A2ABCB11ADORA3SLC5A1SLC6A4
SCHEMBL154701 0.86 SLC5A2 (0.54) SLC5A2ABCB11ADORA3SLC5A1SLC6A4
SCHEMBL152479 0.86 HDAC6 (0.42) CYP2A6CYP2C9CYP2C19CYP2E1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111077235-B Method for determining 2- [ (2-methyl-5-bromophenyl) methyl ] -5- (4-fluorophenyl) thiophene impurity 重庆医药工业研究院有限责任公司 2023-09-08 — — CN claimed
US-11852970-B2 Material for lithography, production method therefor, composition for lithography, pattern formation method, compound, resin, and method for purifying the compound or the resin MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-12-26 — — US disclosed
CN-111077235-B Method for determining 2- [ (2-methyl-5-bromophenyl) methyl ] -5- (4-fluorophenyl) thiophene impurity 重庆医药工业研究院有限责任公司 2023-09-08 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11852970-B2 Material for lithography, production method therefor, composition for lithography, pattern formation method, compound, resin, and method for purifying the compound or the resin SLC39A11, CROCC, TERB1 CYP2A6 3824/4885CYP2C9 2626/4885CYP2C19 3871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback